Literature DB >> 20585819

A case of subarachnoid hemorrhage with pituitary apoplexy caused by idiopathic hypertrophic pachymeningitis.

Shoko M Yamada1, Makoto Aoki, Makoto Nakane, Hitoshi Nakayama.   

Abstract

Steroid therapy is considered to improve clinical symptoms in hypertrophic pachymeningitis. We present a 70-year-old man with idiopathic hypertrophic pachymeningitis, whose clinical signs progressively worsened despite steroid therapy. He died of subarachnoid hemorrhage (SAH) with pituitary apoplexy 2 months after the admission regardless of improvement of laboratory data and magnetic resonance imaging appearance by one-and-half-month steroid therapy. Autopsy revealed thickened dura mater supporting the diagnosis of hypertrophic pachymeningitis. Brain parenchyma is generally not affected by the disease; however, histological investigation suggested that inflammation of the dura caused damage to superior hypophyseal artery resulting in SAH and apoplexy in the anterior lobe of the pituitary gland. The higher dose and the longer duration of steroid therapy should have achieved in our case although most laboratory data recovered within the normal range. The aggressiveness of hypertrophic pachymeningitis must be evaluated by clinical signs rather than by laboratory data or imaging examinations.

Entities:  

Mesh:

Year:  2010        PMID: 20585819     DOI: 10.1007/s10072-010-0343-0

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  16 in total

1.  Idiopathic hypertrophic cranial pachymeningitis: clinicoradiological spectrum and therapeutic options.

Authors:  N Hatano; S Behari; T Nagatani; M Kimura; K Ooka; K Saito; J Yoshida
Journal:  Neurosurgery       Date:  1999-12       Impact factor: 4.654

2.  Hypertrophic cranial pachymeningitis involving the pituitary gland: a case report.

Authors:  R Kitai; K Sato; T Kubota; M Kabuto; H Uno; H Kobayashi
Journal:  Surg Neurol       Date:  1997-07

3.  Idiopathic hypertrophic pachymeningitis - case report and literature review.

Authors:  Adam Rudnik; Dawid Larysz; Jacek Gamrot; Aleksandra Rudnik; Anna Skorupa; Grazyna Bierzyńska-Macyszyn; Piotr Bazowski
Journal:  Folia Neuropathol       Date:  2007       Impact factor: 2.038

4.  Idiopathic hypertrophic cranial pachymeningitis successfully treated with weekly subcutaneous methotrexate.

Authors:  J L Ruiz-Sandoval; G Bernard-Medina; E J Ramos-Gómez; S Romero-Vargas; S Gutiérrez-Ureña; S González-Cornejo; E Chiquete
Journal:  Acta Neurochir (Wien)       Date:  2006-04-18       Impact factor: 2.216

Review 5.  Fibrosing pseudotumor of the sella and parasellar area producing hypopituitarism and multiple cranial nerve palsies.

Authors:  P R Olmos; J M Falko; G L Rea; C P Boesel; D W Chakeres; D B McGhee
Journal:  Neurosurgery       Date:  1993-06       Impact factor: 4.654

Review 6.  Idiopathic hypertrophic pachymeningitis.

Authors:  M J Kupersmith; V Martin; G Heller; A Shah; H J Mitnick
Journal:  Neurology       Date:  2004-03-09       Impact factor: 9.910

7.  Idiopathic hypertrophic cranial pachymeningitis.

Authors:  S R Hamilton; C H Smith; S Lessell
Journal:  J Clin Neuroophthalmol       Date:  1993-06

8.  Hypertrophic cranial pachymeningitis due to Aspergillus flavus.

Authors:  H Murai; J Kira; T Kobayashi; I Goto; H Inoue; K Hasuo
Journal:  Clin Neurol Neurosurg       Date:  1992       Impact factor: 1.876

9.  Idiopathic hypertrophic cranial pachymeningitis associated with hydrocephalus and myocarditis: remarkable steriod-induced remission of hypertrophic dura mater.

Authors:  M Tanaka; M Suda; Y Ishikawa; J Fujitake; H Fujii; Y Tatsuoka
Journal:  Neurology       Date:  1996-02       Impact factor: 9.910

Review 10.  Idiopathic hypertrophic cranial pachymeningitis treated by oral methotrexate: a case report and review of literature.

Authors:  T Bosman; C Simonin; D Launay; S Caron; A Destée; L Defebvre
Journal:  Rheumatol Int       Date:  2007-12-19       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.